7 results
RIPE Therapy - Drug Regimens for Microbiologically Confirmed Pulmonary Tuberculosis - IDSA Guidelines

#Tuberculosis #ActiveTB #RIPE #Therapy
Microbiologically Confirmed Pulmonary ... #ActiveTB #RIPE ... Therapy #regimens #medications ... #pharmacology # ... IDSA #Guidelines #Treatment
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
assay (IGRA) • PPD ... Treatment: Active ... Initiating Treatment ... TB #Diagnosis #Management ... #Treatment #ActiveTB
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
assay (IGRA) • PPD ... Treatment: Active ... Initiating Treatment ... TB #Diagnosis #Management ... #Treatment #ActiveTB
Gastroesophageal Reflux Disease (GERD) - Summary

GERD: Diagnosis
• Heartburn (substernal burning sensation) and acid regurgitation
• Chest pain
Extraesophageal
regurgitation • Chest pain ... manifestations • Chest pain ... Laryngeal and pulmonary ... Incomplete/relief/treatment ... Disease #diagnosis #management
Pearls for Treatment of Alcohol Use Disorder

First-line pharmacotherapies for moderate to severe AUD include naltrexone and
include abdominal pain ... cirrhosis or who are actively ... #UseDisorder #Management ... Screening #Addiction #Medications ... #Pharmacology
Treatment Options for Helicobacter Pylori and Peptic Ulcer Disease

Active Helicobacter pylori—associated ulcer
1. Treat with anti—H pylori
Ulcer Disease Active ... Active ulcer not ... #Treatment #Management ... #Pharmacology # ... Medications
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
Mycobacterium Tuberculosis ... prevent TB disease) Indications ... Mycobacterium #Tuberculosis ... #management #opportunistic ... infections #HIVAIDS #pharmacology